Types and Diagnosis of Salivary Gland Tumors
- Pleomorphic adenoma
- Mucoepidermoid carcinoma
- Adenoid cystic carcinoma
- Acinic cell carcinoma
- Warthin tumor
- Physical examination
- Imaging tests (ultrasound, CT scan, MRI)
- Fine needle aspiration cytology (FNAC)
- Histopathology
- Molecular testing

Treatment Options for Salivary Gland Tumors
- Surgery (partial or complete removal of the tumor)
- Radiation therapy
- Chemotherapy
- Targeted therapy
- Palliative care

Prognosis and Survival Rates of Salivary Gland Tumors
- Prognosis depends on the type and stage of the tumor
- Five-year survival rates vary depending on the tumor type (ranging from 20% to 85%)
- Factors affecting prognosis include tumor size, location, grade, and presence of metastasis
- Recurrence rates vary depending on the tumor type (ranging from 10% to 80%)
- Regular follow-up and monitoring are important for early detection of recurrence

Risk Factors of Salivary Gland Tumors
- Radiation exposure (e.g., previous radiation therapy)
- Environmental factors (e.g., exposure to certain chemicals)
- Family history of salivary gland tumors
- Age (most common in adults over 40)
- Gender (some tumor types are more common in males)

Epidemiology of Salivary Gland Tumors
- Limited knowledge of total incidence due to unrecorded benign tumors
- Majority of salivary tumors are benign (65-70%)
- Higher incidence of benign tumors in parotid gland (75-80%)
- Submandibular gland tumors are 50% benign
- Sublingual gland tumors are rare but more likely to be malignant